Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...

Since first introduced, anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies and CGRP antagonists (gepants) have had a transformative impact on migraine management, both preventive and ...

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

Calcitonin gene-related peptide (CGRP) inhibitors -- a group of drugs commonly used to treat migraine -- were associated with decreased rates of acne and rosacea compared with drugs that did not ...

According to current data, migraines are one of the most common neurological disorders worldwide and in the United States. Worldwide, migraines affect about 40% of the population (3.1 billion people).

Slate Medicines, a new Raleigh biotechnology company developing treatments for migraine and headache disorders, has announced ...

A recently approved drug can diminish early symptoms of migraine Ubrogepant warded off light and sound sensitivity, neck pain and fatigue that come before a headache Patients also said the drug helped ...